Cannabidiol (CBD) and Alzheimer‘s: New study shows potential for brain and memory

This article summarizes the most important findings in an understandable way and shows why CBD in Alzheimer’s is increasingly coming into the focus of research.

What is Alzheimer’s and why is the disease so difficult to treat?

Alzheimer’s disease is the most common form of dementia and affects millions of people worldwide. It is characterized by:

• Deposits of β-Amyloid (Aβ) plaques
• Formation of Tau protein clumps
• Chronic neuroinflammation
• Progressive loss of nerve cells

These processes lead to a gradual decline in memory, language, and cognitive abilities. According to the current study, there is no cure so far – existing medications only aim at symptom control.

What is CBD and how does it work in the body?

CBD (Cannabidiol) is a non-psychoactive component of the cannabis plant and interacts with the so-called endocannabinoid system (ECS). This system plays a central role in:

• Memory and learning
• Inflammation regulation
• Neuronal protection (neuroprotection)

CBD acts on various receptors, especially:

• CB1 receptors (in the brain)
• CB2 receptors (in the immune system)

Additionally, CBD also affects other systems such as serotonin or adenosine receptors, explaining its versatile effects.

Key findings of the study: How CBD can work in Alzheimer’s

1. Reduction of amyloid and tau deposits

A central finding of the study is that CBD significantly reduces the aggregation of Aβ and tau. These protein deposits are considered the main drivers of the disease.

Furthermore, it was shown that CBD also reduces the transport of these harmful proteins between nerve cells – a possible key mechanism for slowing the progression of the disease.

2. Strong anti-inflammatory effect

Chronic neuroinflammation plays a crucial role in Alzheimer’s. CBD demonstrated in the study:

• Reduction of proinflammatory cytokines (e.g., IL-1β)
• Increase of anti-inflammatory factors (e.g., IL-10)
• Reprogramming of microglia into a neuroprotective state (M2 phenotype)

These effects suggest that CBD can specifically modulate inflammation in the brain.

3. Protection of nerve cells and antioxidant effects

Another important mechanism is the reduction of oxidative stress. The study shows:

• Reduction of reactive oxygen species (ROS)
• Increased survival rate of nerve cells
• Protection against toxic effects from amyloid proteins

These antioxidant properties are crucial as oxidative stress significantly contributes to cell damage.

4. Improvement of neuronal plasticity

The brain’s ability to form new connections – the so-called neuronal plasticity – is severely impaired in Alzheimer’s.

CBD was able to:

• Partially reverse the loss of neurites (nerve extensions)
• Stabilize synaptic structures
• Promote regeneration processes

This is particularly relevant as plasticity is the basis for learning and memory.

5. Improved memory performance in animal models

Especially impressive are the results regarding cognitive performance:

• Improvements in short-term memory
• Improvements in long-term memory
• Reduction of Alzheimer-typical behavioral deficits

These effects were confirmed in various animal models and demonstrate the potential of CBD to improve cognitive function.

Why CBD is considered a “multifunctional active ingredient”

A decisive advantage of CBD is its broad spectrum of action. While many drugs address only one mechanism, CBD acts simultaneously on several central disease processes:

• Protein aggregation
• Inflammation
• Oxidative stress
• Neuroprotection
• Cognitive functions

This so-called “multi-target strategy” could be a decisive breakthrough in Alzheimer’s therapy.

Limitations of current research

Despite the promising results, caution is advised:

• Most data come from preclinical studies (cell cultures and animal models)
• Long-term studies in humans are still lacking
• Dosing and application are not yet standardized

The authors therefore emphasize that further clinical studies are necessary to clearly demonstrate efficacy in humans.

Conclusion: Does CBD have the potential to change Alzheimer’s?

Current research clearly shows: CBD is one of the most promising candidates in Alzheimer’s research. Due to its ability to simultaneously influence several disease-relevant processes, CBD could play an important role in the future – especially in the early phase of the disease or as a complementary therapy. Nevertheless, CBD is currently not a substitute for medical treatment but an exciting research approach with great potential. Regardless of the current study situation, many people are interested in CBD oil as a practical and uncomplicated way to integrate cannabidiol into everyday life. Quality, transparency, and an individually suitable application are important.

Source reference: Raïch I, Lillo J, Rebassa JB et al. Cannabidiol as a multifaceted therapeutic agent: mitigating Alzheimer's disease pathology and enhancing cognitive function. Alzheimer’s Research & Therapy. 2025;17:109. doi:10.1186/s13195-025-01756-0.

Images: HANAFSAN & Atlascompany on Freepik